Revue d'utilisation de deux anticoagulants oraux dans un CHU français : dabigatran etexilate et rivaroxaban

Reviewing the use of dabigatran and rivaroxaban help to define the profile of patients using such medications, to highlight how to use these two anticoagulants, to identify adverse effects. The results show no particular concern with the prescription and administration of these two anticoagulants.